We are live on ! Find out more
BCAB icon

BioAtla

86 hedge funds and large institutions have $746M invested in BioAtla in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 15

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

13% more funds holding

Funds holding: 7686 (+10)

0.25% more ownership

Funds ownership: 1.32%1.57% (+0.25%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

17% less capital invested

Capital invested by funds: $897M → $746M (-$150M)

Holders
86
Holders Change
+10
Holders Change %
+13.16%
% of All Funds
1.51%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
22
Increased
37
Reduced
15
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Point72 Asset Management
26
Point72 Asset Management
Connecticut
$3.79M +$5.01M +2,572 New
Charles Schwab
27
Charles Schwab
California
$3.26M +$1.24M +637 +40%
Hudson Bay Capital Management
28
Hudson Bay Capital Management
Connecticut
$1.95M +$2.78M +1,428 New
N
29
Nuveen
North Carolina
$1.89M +$861K +442 +53%
Millennium Management
30
Millennium Management
New York
$1.84M +$2.44M +1,251 New
PIM
31
Platinum Investment Management
Australia
$1.67M +$894K +459 +68%
EC
32
EcoR1 Capital
California
$1.47M
Goldman Sachs
33
Goldman Sachs
New York
$1.38M +$1.37M +705 +308%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.29M +$501K +257 +42%
Swiss National Bank
35
Swiss National Bank
Switzerland
$1.25M +$959K +492 +137%
AA
36
ALPS Advisors
Colorado
$1.22M -$35.1K -18 -2%
Rafferty Asset Management
37
Rafferty Asset Management
New York
$1.17M +$559K +287 +56%
UBS Group
38
UBS Group
Switzerland
$1.16M +$1.45M +746 +1,658%
MWNA
39
Marshall Wace North America
New York
$960K +$56.5K +29 +5%
CSS
40
Cubist Systematic Strategies
Connecticut
$935K +$1.24M +636 New
Voloridge Investment Management
41
Voloridge Investment Management
Florida
$901K +$1.19M +612 New
Citigroup
42
Citigroup
New York
$792K -$508K -261 -33%
JP Morgan Chase
43
JP Morgan Chase
New York
$780K +$705K +362 +215%
JF
44
Jump Financial
Illinois
$767K +$563K +289 +125%
BFM
45
Boothbay Fund Management
New York
$748K +$522K +268 +112%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$727K +$621K +319 +182%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$712K +$288K +148 +44%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$459K
TI
49
Trexquant Investment
Connecticut
$440K +$583K +299 New
TRSOTSOK
50
Teachers Retirement System of the State of Kentucky
Kentucky
$413K +$545K +280 New

BCAB Hedge Fund Activity: Q3 2021 in Review

86 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q3 2021, worth a combined $746M — down 17% from $897M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new BCAB positions and 12 closed out — a net gain of 10 holders — while 37 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $40.6M. The largest seller was Farallon Capital Management, cutting an estimated $28.1M.

  • 86 institutional investors held BioAtla (BCAB) as of Q3 2021, up from 76 in Q2 2021.
  • Funds reported $746M of BioAtla stock for Q3 2021, down 17% quarter-over-quarter.
  • 22 funds opened new BioAtla positions in Q3 2021 and 12 closed out, a net change of +10 holders.
  • The largest BioAtla buyer in Q3 2021 was Vanguard Group, an estimated $40.6M added.
  • The largest BioAtla seller in Q3 2021 was Farallon Capital Management, an estimated $28.1M sold.

Based on aggregated 13F filings for Q3 2021.